Pioglitazone Ameliorates Intracerebral Insulin Resistance and Tau-Protein Hyperphosphorylation in Rats With Type 2 Diabetes

Experimental and Clinical Endocrinology and Diabetes - Germany
doi 10.1055/s-0032-1333277
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Pioglitazone and Cardiovascular Outcomes in Patients With Insulin Resistance, Pre-Diabetes and Type 2 Diabetes: A Systematic Review and Meta-Analysis

BMJ Open
Medicine
2017English

Postprandial Hyperaminoacidaemia Overcomes Insulin Resistance of Protein Anabolism in Men With Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Etiology of Insulin Resistance in Youth With Type 2 Diabetes

Current Diabetes Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Insulin Resistance in the Offspring of Parents With Type 2 Diabetes

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2005English

The Effect of Acetylsalicylic Acid on Vasopressin, Serum Insulin Levels, Insulin Resistance, and Biochemical Parameters in Rats Induced With Experimental Diabetes Type 2

Turkish Journal of Medical Sciences
Medicine
2017English

Serum Insulin and Insulin Resistance in the Off-Springs of Type 2 Diabetes Mellitus

Journal of Diabetes & Metabolism
2014English

Role of Insulin Resistance in the Pathogenesis and Development of Type 2 Diabetes in WBN/Kob-Leprfa Rats

Journal of Veterinary Medical Science
Veterinary
2013English

Beneficial Effects of Canagliflozin in Combination With Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes

PLoS ONE
Multidisciplinary
2015English

Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia

Frontiers in Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy